← Back to Clinical Trials
Recruiting NCT07200258

NCT07200258 Changes in Soft Tissue Thickness Following Multiple Coronally Advanced Tunnel (MCAT) vs Vestibular Incision Subperiosteal Tunnel Access (VISTA)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07200258
Status Recruiting
Phase
Sponsor Universidad Complutense de Madrid
Condition Gingival Recession
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-10-15
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Vestibular Incision Subperiosteal Tunnel Access (VISTA)Modified Coronally Advanced Tunnel (MCAT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-10-15 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial will compare two surgical methods for treating multiple adjacent gingival recessions (types RT1 and RT2): the Modified Coronally Advanced Tunnel (MCAT) and the Vestibular Incision Subperiosteal Tunnel Access (VISTA). Both methods will use connective tissue grafts (CTG), which are the best way to cover roots. The main objective is to use three-dimensional (3D) digital volumetric analysis to look at how the thickness of soft tissue has changed after six and 12 months. Secondary outcomes include root coverage, esthetic outcomes, gingival health parameters, hypersensitivity, patient satisfaction, and wound healing quality. There will be 44 volunteers, and they will be randomly assigned to one of the two surgical methods. Under the same settings, periodontal specialists in training will undertake the procedures at the Universidad Complutense de Madrid. There will be follow-up evaluations at different times up to 12 months after the procedure. The results of this study will help determine whether remote incisions via the VISTA technique offer improved outcomes compared to the MCAT technique.

Eligibility Criteria

Inclusion Criteria: * Periodontally and systemically healthy adults (age ≥ 18 years). * At least two adjacent sites exhibiting gingival recessions classified as recession type 1 (RT1) o type 2 (RT2) (Cairo et al., 2011), associated with dental hypersensitivity or aesthetic concerns. * Presence ≥2 mm depth on at least one recession * Smokers ≤ 10 cigarettes. * Full-mouth plaque and bleeding scores ≤20%. * Patients being able to maintain good oral hygiene. Exclusion Criteria: * Compromised general health. * Pregnancy or attempting to get pregnant (self-reported). * Untreated periodontal diseases * Presence of: (i) severe tooth malposition; (ii) root caries or inadequate prosthetic restorations; (iii) previous periodontal plastic surgery at the experimental sites. * Smokers \>10 cigarettes

Contact & Investigator

Central Contact

Ana Carrillo de Albornoz Sainz

✉ acarri02@ucm.es

📞 +34 627588248

Frequently Asked Questions

Who can join the NCT07200258 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07200258 currently recruiting?

Yes, NCT07200258 is actively recruiting participants. Contact the research team at acarri02@ucm.es for enrollment information.

Where is the NCT07200258 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT07200258 clinical trial?

NCT07200258 is sponsored by Universidad Complutense de Madrid. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology